PCa Risk Higher In Men with Heart Disease

Share this article:

Coronary artery disease (CAD) was associated with a 35% increased risk of a prostate cancer (PCa) diagnosis among the 6,390 men taking part in the REDUCE trial, which evaluated whether dutasteride reduced PCa risk. Overall, 547 enrollees (8.6%) had a history of CAD.

Compared with men who had no heart disease, those with CAD were 24% more likely to be diagnosed with PCa two years into the REDUCE trial and 74% more likely four years into the study, Stephen J. Freedland, MD, and colleagues reported in Cancer Epidemiology, Biomarkers & Prevention.

Share this article:
You must be a registered member of RUN to post a comment.
close

Next Article in News in Brief

More in News in Brief

Urodynamic Studies On the Upswing

Urodynamic Studies On the Upswing

Urodynamic studies for female Medicare patients increased by 29% from 2000 to 2010.

FDA Okays Rapid-Acting Inhaled Insulin

FDA Okays Rapid-Acting Inhaled Insulin

Afrezza is administered at the start of each meal or within 20 minutes after starting a meal.

Ureteroscopy Use for Stones Increasing

Ureteroscopy Use for Stones Increasing

Researchers found increasing use of ureteroscopy and decreasing use of shock wave lithotripsy.